国药现代：关于公开挂牌转让控股子公司股权进展暨完成工商变更的公告

Core Points - The company announced the completion of the transfer of 51% equity in Shanghai Modern Harsen (Shangqiu) Pharmaceutical Co., Ltd. to Henan Yangsen Pharmaceutical Group Co., Ltd. for a price of 109.68 million yuan [1] - The company has received the full payment for the equity transfer and has completed the necessary industrial and commercial registration changes [1] - Following the transfer, the company no longer holds any equity in Shanghai Modern Harsen and has no form of association, control, or substantial management relationship with it [1]